Ispecimen Inc (ISPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 696 | 54 | N/A | N/A |
| Receivables | 2,359 | 1,393 | N/A | N/A |
| TOTAL | $3,472 | $1,581 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 76 | 120 | N/A | N/A |
| Other Non-Current Assets | 2,662 | 2,514 | 0 | 0 |
| TOTAL | $2,737 | $2,634 | $N/A | $N/A |
| Total Assets | $6,210 | $4,215 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 1,792 | 738 | 0 | 0 |
| Accrued Expenses | 4,508 | 2,217 | N/A | N/A |
| Other current liabilities | 2,373 | 2,214 | N/A | N/A |
| TOTAL | $22,136 | $15,760 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Deferred Revenues | 873 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 179 | 0 | 0 | 0 |
| TOTAL | $179 | $N/A | $N/A | $N/A |
| Total Liabilities | $22,315 | $15,760 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Retained earnings | -29,058 | -24,406 | N/A | N/A |
| Other shareholders' equity | 11,173 | 11,173 | 0 | 0 |
| TOTAL | $-16,105 | $-11,546 | $N/A | $N/A |
| Total Liabilities And Equity | $6,210 | $4,215 | $0 | $0 |